Development of In Situ Film as Skin Barrier

Suwannee Panomsuk; Karnjanolarn Jarunan; Chinpongsanond Laksika; Tachasan Sirapong; Rungruang Adchara

doi:10.4028/www.scientific.net/AMM.378.190

Paper Titles

Carbon Nanotubes: Good Candidate for VLSI Interconnects
p.165

Heat Transfer Improvement between Copper Film and Ceramic Substrate by Thermal Treatment
p.172

Constitutive and Processing Map Analyses of Stainless Steel 316 under Hot Compression
p.178

Statistical Analysis of the Factors Effect on the Zinc Coating Thickness
p.184

Development of In Situ Film as Skin Barrier
p.190

Microstructure Analysis on LILW Waste Disposal Facility by Accelerated Steel Corrosion Tests
p.194

ZnO Nanorods on Polymer Substrate by Solution Method
p.198

Effect of Sintering Temperature on Structural and Electrical Transport Properties of (La_0.7Ca_0.3MnO₃)_0.97/(ZnO)_0.03 Composite
p.202

Effect of Electrolytes Variation on the Formation of Oxide Layers of Al7075 Alloys by Electrolytic Plasma Processing
p.209

HomeApplied Mechanics and MaterialsApplied Mechanics and Materials Vol. 378Development of In Situ Film as Skin Barrier

Development of In Situ Film as Skin Barrier

Abstract:

In situ film or liquid plaster, a medical product for topical use, was developed using various polymers and plasticizers. The film bases were formulated and evaluated for their physical appearances, tensile properties, integrity on porcine skin, powder x-ray diffraction (PXRD) and drug release. Formulations containing Eudragit^® L100 and triethyl citrate (TEC) or PEG 400 represent good films. Benzalkonium chloride (BZCl), 0.4 % w/w, was also added in these formulations as anti-infective agents. Films containing Eudragit^® L100 and TEC have revealed the most suitable properties as topically applicable plaster film: good physical appearance as well as adhesion on the porcine skin. A soft and tough film was also obtained from the formulation containing Eudragit^® L100 and TEC. PXRD results have shown that drug exist in amorphous form in all formulations. The percentages of drug release among three formulations within 3 hours are between 8-12%. In conclusion, formulation containing Eudragit^® L100 and TEC have revealed the most suitable properties as topically applicable plaster film.